These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis. Terayama R, Bando Y, Yamada M, Yoshida S. Glia; 2005 Nov 01; 52(2):108-18. PubMed ID: 15920728 [Abstract] [Full Text] [Related]
32. Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response. Wu Z, Nagano I, Asano K, Takahashi Y. Parasitol Res; 2010 Oct 01; 107(5):1173-88. PubMed ID: 20661746 [Abstract] [Full Text] [Related]
38. Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Dziennis S, Mader S, Akiyoshi K, Ren X, Ayala P, Burrows GG, Vandenbark AA, Herson PS, Hurn PD, Offner HA. Metab Brain Dis; 2011 Jun 01; 26(2):123-33. PubMed ID: 21472429 [Abstract] [Full Text] [Related]
39. Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis. Weinger JG, Brosnan CF, Loudig O, Goldberg MF, Macian F, Arnett HA, Prieto AL, Tsiperson V, Shafit-Zagardo B. J Neuroinflammation; 2011 May 15; 8():49. PubMed ID: 21569627 [Abstract] [Full Text] [Related]
40. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE. Mony JT, Khorooshi R, Owens T. Mult Scler; 2014 Sep 15; 20(10):1312-21. PubMed ID: 24552747 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]